Article thumbnail

Environ Health

By 

Abstract

BackgroundCYP19 and PPAR\uce\ub3 are two genes expressed in the placental trophoblast that are important to placental function and are disrupted by phthalate exposure in other cell types. Measurement of the mRNA of these two genes in human placental tissue by quantitative real-time polymerase chain reaction (qPCR) offers a source of potential biomarkers for use in epidemiologic research. We report on methodologic challenges to be considered in study design.MethodsWe anonymously collected 10 full-term placentas and, for each, sampled placental villi at 12 sites in the chorionic plate representing the inner (closer to the cord insertion site) and outer regions. Each sample was analyzed for the expression of two candidate genes, aromatase (CYP19) and peroxisome proliferator activated receptor protein gamma (PPAR\uce\ub3) and three potential internal controls: cyclophilin (CYC), 18S rRNA (18S), and total RNA. Between and within placenta variability was estimated using variance component analysis. Associations of expression levels with sampling characteristics were estimated using mixed effects models.ResultsWe identified large within-placenta variability in both transcripts (>90% of total variance) that was minimized to <20% of total variance by using 18S as an internal control and by modelling the means by inner and outer regions. 18S rRNA was the most appropriate internal control based on within and between placenta variability estimates and low correlations of 18S mRNA with target gene mRNA. Gene expression did not differ significantly by delivery method. We observed decreases in the expression of both transcripts over the 25 minute period after delivery (CYP19 p-value for trend = 0.009 and PPAR\uce\ub3 (p-value for trend = 0.002). Using histologic methods, we confirmed that our samples were comprised predominantly of villous tissue of the fetal placenta with minimal contamination of maternally derived cell types.ConclusionqPCR-derived biomarkers of placental CYP19 and PPAR\uce\ub3 gene expression show high within-placental variability. Sampling scheme, selection of an appropriate internal control and the timing of sample collection relative to delivery can be optimized to minimize within-placenta and other sources of underlying, non-etiologic variability.R01 ES013543/ES/NIEHS NIH HHS/United StatesT42 OH008416/OH/NIOSH CDC HHS/United States19389254PMC267811

Topics: Methodology, Aromatase, Biological Markers, Cyclophilins, Female, Gene Expression, Gene Expression Regulation, Humans, PPAR gamma, Phthalic Acids, Placenta, RNA, Messenger, RNA, Ribosomal, 18S, Reverse Transcriptase Polymerase Chain Reaction, Transcription, Genetic
OAI identifier: oai:cdc.stacks:cdc:22971
Provided by: CDC Stacks
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://stacks.cdc.gov/view/cdc... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles